Clinical Trials Directory

Trials / Completed

CompletedNCT05977959

Optimizing the Impact of the Healthy School Recognized Campus Program on Youth's CVD Risk Factors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
159 (actual)
Sponsor
Texas A&M University · Academic / Other
Sex
All
Age
10 Years – 14 Years
Healthy volunteers
Accepted

Summary

Healthy School Recognized Campus is a Texas A\&M AgriLife Extension initiative that supports the delivery of school-based physical activity and nutrition programs for diverse youth across Texas. The purpose of this study is to improve the delivery of these programs and optimize the effect they have on youth's cardiovascular risk factors.

Detailed description

The investigators will conduct a group randomized factorial trial using the Multiphase Optimization STrategy (MOST) framework to evaluate the impact (i.e., implementation and effectiveness) of three implementation strategies on program implementation and youth's cardiovascular disease risk. HSRC is a Texas A\&M AgriLife Extension initiative that supports the delivery of school-based physical activity and nutrition programs. Elementary schools in North and East Texas (n=16) of similar socio-economic status will be randomized at baseline to receive either 3, 2, 1, or no strategies to support HSRC program implementation. All schools will participate in HSRC during the full school year. The investigators hypothesize that one strategy will result in significantly greater HSRC implementation and effectiveness than the other strategies tested.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMentoring ProgramSchools in this group will participate in meetings and discussion boards and receive newsletters to help with program implementation.
BEHAVIORALEnhanced ResourcesSchools in this group will receive extra resources such as program incentives to aid in program implementation.
BEHAVIORALEnhanced EngagementSchools in this group will participate in program contests to aid program implementation.

Timeline

Start date
2023-09-13
Primary completion
2025-06-30
Completion
2025-06-30
First posted
2023-08-07
Last updated
2025-09-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05977959. Inclusion in this directory is not an endorsement.